ConductScience.org, home

Trial · NCT02924727

Results by group24

Each measurement the trial posted, group by group, in the words and numbers it posted.

OutcomeGroupCategoryValueSpreadUnits
Number of Participants With First CEC (Clinical Endpoint Committee) Confirmed Primary Composite EndpointLCZ696 (Sacubitril/Valsartan)Primary Composite338Count of Participants
Number of Participants With First CEC (Clinical Endpoint Committee) Confirmed Primary Composite EndpointRamiprilPrimary Composite373Count of Participants
Number of Participants With First CEC (Clinical Endpoint Committee) Confirmed Primary Composite EndpointLCZ696 (Sacubitril/Valsartan)Cardiovascular (CV) Death168Count of Participants
Number of Participants With First CEC (Clinical Endpoint Committee) Confirmed Primary Composite EndpointRamiprilCardiovascular (CV) Death191Count of Participants
Number of Participants With First CEC (Clinical Endpoint Committee) Confirmed Primary Composite EndpointLCZ696 (Sacubitril/Valsartan)First Heart Failure (HF) Hospitalization170Count of Participants
Number of Participants With First CEC (Clinical Endpoint Committee) Confirmed Primary Composite EndpointRamiprilFirst Heart Failure (HF) Hospitalization195Count of Participants
Number of Participants With First CEC (Clinical Endpoint Committee) Confirmed Primary Composite EndpointLCZ696 (Sacubitril/Valsartan)First Outpatient Heart Failure (HF)39Count of Participants
Number of Participants With First CEC (Clinical Endpoint Committee) Confirmed Primary Composite EndpointRamiprilFirst Outpatient Heart Failure (HF)57Count of Participants
Number of Participants With a Confirmed Composite of CV Death or HF HospitalizationLCZ696 (Sacubitril/Valsartan)308Participants
Number of Participants With a Confirmed Composite of CV Death or HF HospitalizationRamipril335Participants
Number of Participants With a Confirmed Composite of HF Hospitalization or Outpatient HFLCZ696 (Sacubitril/Valsartan)201Participants
Number of Participants With a Confirmed Composite of HF Hospitalization or Outpatient HFRamipril237Participants
Number of Participants With a Confirmed Composite of CV Death, Non-fatal Spontaneous Myocardial Infarction or Non-fatal StrokeLCZ696 (Sacubitril/Valsartan)315Participants
Number of Participants With a Confirmed Composite of CV Death, Non-fatal Spontaneous Myocardial Infarction or Non-fatal StrokeRamipril349Participants
Total Number of Confirmed Composite EndpointsLCZ696 (Sacubitril/Valsartan)416Events
Total Number of Confirmed Composite EndpointsRamipril455Events
All-cause Mortality for Full Analysis Set (FAS)LCZ696 (Sacubitril/Valsartan)213Participants
All-cause Mortality for Full Analysis Set (FAS)Ramipril242Participants
All Collected DeathsLCZ696 (Sacubitril/Valsartan)pre-treatment deaths1Participants
All Collected DeathsRamiprilpre-treatment deaths3Participants

Source ClinicalTrials.govtrials-2026-11-12-0.4.0

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNone stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/trials/v1/NCT02924727/results